• Home
  • Capabilities - Assay Development

Assay Development Services

Developing Assays for Product Release Testing

Let our team of specialized experts help you develop assays for your product release testing. Provide us with your virus vector and we will develop the assay for detecting replication competent virus.

Plaque Assay

Determines infectious virus particles in a sample. Virus is sequentially diluted and dilutions are plated on susceptible cells. Cultures are overlaid with nutrient agarose and plaques or pocks formed by cytopathic viruses can be quantitated.

Plaque Inhibition Assay

This assay is requested frequently to test the efficacy of antiviral drug candidates. Drug is included in the agarose overlay and if effective will reduce the size and/or number of plaques observed.

TCID50 Assay

Quantitates infectious virus particles in a sample. Virus is sequentially diluted and dilutions are plated in replicate wells of susceptible cells. The TCID50 (50% Tissue Culture Infectious Dose) is that dilution of virus which will produce pathological change in fifty percent of cell cultures inoculated at a particular dilution. TCID50 values are normally very close to the Plaque Assay values for most cytopathic viruses.

IC50 Assay

This assay is requested frequently to test the efficacy of antiviral drug candidates. Drug is included in the agarose overlay and if effective will reduce the size and/or number of plaques observed.

Fluorometric Neuraminidase Assay

This assay measures a fluorogenic substance released by the active influenza neuraminidase enzyme. It is used to screen for antiviral drug activity against neuraminidase and determine the 50% Drug Inhibitory Dose.

SRID Assay

The SRID Assay is used to quantitate the amount of antigen in a sample. Antigen concentration is determined by the degree of antigen/antibody precipitate around a well into which detergent solubilized virus is placed. A standardized antigen preparation and a specific polyclonal antibody are required.

Hemagglutination Assay

Detects the presence of certain viruses that agglutinate red blood cells. This assay can be used to quantitate or type many virus strains. For example, influenza virus possesses the capacity to agglutinate red blood cells of specific animal species. It does this by cross linking sialic acid residues on the surface of red blood cells. In some labs, the hemagglutination assay is preferred for detecting influenza virus growth. The hemagglutination titer of an influenza virus sample can be determined when dilutions of virus are mixed with human or turkey red blood cells. The presence of virus will hold the red cells in a diffuse matrix and prevent them from settling out to the bottom of the well.

Hemagglutination Inhibition Assay

This test is based on the inhibition of viral agglutination by a specific antibody and can be used for virus identification or for assay of antibodies. This assay is still used as a standard for measuring the efficacy of influenza vaccines and potency of neutralizing antibodies.

Microneutralization Assay

An excellent test to determine if an antibody may have therapeutic effects. This assay measures the ability of an antiserum to inhibit cytopathogenic effect of about 100 virus infectious units. The antibody/virus mixture is plated on susceptible cells and inhibition is tracked.

EID50 Assay

The 50% Egg Infectious Dose assay is carried out in the same manner as a TCID50 where every well is represented by a unique egg. Each virus dilution is injected into replicate eggs which are tested after a period of incubation for signs of virus growth. In the case of influenza we use the hemagglutination (HA) assay. We utilize other immunological tools for the detection of other viruses.

Textiles and Plastics Assay (AATP)

The antiviral activity of textiles and plastics (AATP) test measures antiviral activity of plastics and other non-porous surfaces treated with antiviral agents. This assay will determine the log reduction of virus compared to the customer supplied untreated control.

Connect with the Assay Development Team

We’re ready to answer your questions.

Business Development
Phone: +1.800.599.2847
Email: businessdevelopment@microbiologics.com

We are the world’s leading experts and go-to collaborators for biological products and services.

Learn more about our capabilities and areas of expertise at each of our locations.